Citation Impact
1 by Nobel laureates 3 from Science/Nature 61 standout
Citing Papers
Targeting immunogenic cell stress and death for cancer therapy
2024 Standout
Renal cell carcinoma
2024 Standout
Works of Fong Wang being referenced
Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Results from 55-month follow-up of the CheckMate 9ER trial.
2024
A phase III study (COSMIC-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poor-risk.
2020
Author Peers
| Author | PRM | Oncology | RNMI | Molecular Biology | Cancer Research | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Fong Wang | 660 | 221 | 178 | 263 | 238 | 26 | 1.1k | |
| K. Bloch | 15 | 2 | 4 | 25 | 9 | 286 | ||
| Stephen E. Wood | 2 | 3 | 14 | 639 | ||||
| Emily Rose | 1 | 18 | 385 | |||||
| S.H. Muhle | 15 | 7 | 24 | 23 | 407 | |||
| Mohammad Gholami | 1 | 2 | 1 | 36 | 274 |
All Works
Loading papers...